testo-alternativo
Cutting-Edge Dermatology: From Urticaria to Androgenetic Alopecia

Advancements in Dermatology: A Weekly Review

Dermatologia e Venerologia

Cutting-Edge Dermatology: From Urticaria to Androgenetic Alopecia

This week we cover groundbreaking treatments for chronic urticaria, innovative approaches to hair loss, the intriguing 'flip-flop' phenomenon in inflammatory skin diseases, and concerns about dermatology smartphone apps.

Accedi o Registrati per ascoltare questo episodio

Bibliografia

1. Randomized dose-finding study of anti-KIT barzolvolimab in patients with chronic spontaneous urticaria.
Authors: Metz M, Mitha E, Leflein J, et al.
Journal: The Journal of allergy and clinical immunology, 2026 Nov
PMID: 41747871
DOI: 10.1016/j.jaci.2026.02.018


2. Safety and pharmacokinetics of anumigilimab for hidradenitis suppurativa or palmoplantar pustulosis: A phase 1b study.
Authors: Kern JS, Thomsen SF, Kokolakis G, et al.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV, 2026 Nov
PMID: 42478283
DOI: 10.1111/jdv.70594


3. Classification of Seasonal Allergic Rhinitis Patients by Prospective Patient-Recorded Symptoms: The @IT.2020 Project.
Authors: Dramburg S, Hernandez Toro CJ, Grittner U, et al.
Journal: Allergy, 2026 Nov
PMID: 42684055
DOI: 10.1111/all.70447


4. Smartphone Applications in Dermatology With Special Focus on AI: A European-Continent-Based Review.
Authors: Sangers T, Shifai AN, Pasqualini DGJ, et al.
Journal: International journal of dermatology, 2026 Nov
PMID: 42458765
DOI: 10.1111/ijd.70582


5. International Multiprofessional Expert Consensus on Acute Minor Wounds: A Practical Decision Framework.
Authors: Teot L, Williams A, Basuki A, et al.
Journal: International wound journal, 2026 Nov
PMID: 42988361
DOI: 10.1111/iwj.71084


6. Microbiome-derived TOPOSCORE is associated with response to immune checkpoint inhibitor re-induction after chemotherapy in primary resistant metastatic melanoma.
Authors: Haferkamp S, Schilling B, Baumgart L, et al.
Journal: Cancer immunology, immunotherapy : CII, 2026 Oct 30
PMID: 42965706
DOI: 10.1007/s00262-026-04618-2


7. Toward Precision Andrology: Advancing Semen Testing to Resolve the Enigma of 'Idiopathic' Male Infertility.
Authors: Sengupta P, Dutta S, Elsuity MAE, et al.
Journal: American journal of men's health, 2026 Nov-Dec
PMID: 43017782
DOI: 10.1177/15579883261506476


8. Thulium laser-assisted delivery of growth factors for treating androgenetic alopecia - a randomized, controlled, clinical study.
Authors: Nguyen L, Schneider SW, Herberger K
Journal: Lasers in medical science, 2026 Oct 22
PMID: 42911445
DOI: 10.1007/s10103-026-05066-1


9. Treatment-associated phenotype switching between psoriasis and atopic dermatitis.
Authors: Torres T, Valenti M, Balato A, et al.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV, 2026 Nov
PMID: 42132049
DOI: 10.1111/jdv.70503


10. Oral deucrictibant for on-demand treatment of hereditary angioedema attacks: a phase 3, multicentre, randomised, double-blind, placebo-controlled crossover trial.
Authors: Riedl MA, Li PH, Adatia A, et al.
Journal: Lancet (London, England), 2026 Oct 24
PMID: 42849489
DOI: 10.1016/S0140-6736(26)01296-1

Commenti

Per favore Accedi per lasciare un commento.

Ancora nessun commento.